FDA approves Crinetics Pharmaceuticals’ first drug

Crinetics Pharmaceuticals just won its first Food and Drug Administration approval with Palsonify, a once-daily pill for adults with acromegaly, a rare and debilitating hormonal disorder, who cannot undergo surgery or did not respond to it. Backed by two late-stage trials showing significant drops in growth hormone and improved symptoms, the small-molecule drug offers patients an oral […]

FDA approves Crinetics Pharmaceuticals’ first drug Read More »